KEGG pathway analysis of this change found that seven of our identified pathways, including MAPK, RAS, mTOR, chemokine, adhesion, FOXO, and WNT, were significantly upregulated in CLL cells taken at DP compared with those taken at BL (Fig. 4E). This evidence concerns the gene MTOR and B-cell chronic lymphocytic leukemia.